Development of rat liver 3D organoid methods to address genotoxicity screening

Information

  • Research Project
  • 10075486
  • ApplicationId
    10075486
  • Core Project Number
    R43ES032345
  • Full Project Number
    1R43ES032345-01
  • Serial Number
    032345
  • FOA Number
    RFA-ES-20-005
  • Sub Project Id
  • Project Start Date
    9/25/2020 - 4 years ago
  • Project End Date
    8/31/2021 - 3 years ago
  • Program Officer Name
    SHAUGHNESSY, DANIEL
  • Budget Start Date
    9/25/2020 - 4 years ago
  • Budget End Date
    8/31/2021 - 3 years ago
  • Fiscal Year
    2020
  • Support Year
    01
  • Suffix
  • Award Notice Date
    9/25/2020 - 4 years ago

Development of rat liver 3D organoid methods to address genotoxicity screening

Project Summary Studying cells in simple 2D culture systems has many advantages with of ease of use, ability to screen many conditions in a short amount of time, targeted addition or deletion of genes, proteins or other components and focused study of specific pathways representing only a few. However, that simplicity can also lead to loss of key functions and an overall lack of relevancy to whole organisms, especially humans. In an effort to bridge this gap between cells in a dish and a human being, in vitro models are being developed that mimic the function of whole organs, so-called organotypic cultures. These models represent an opportunity to study highly complex, multicellular systems that will respond more like actual organs as opposed to cells grown in a simple monolayer. Our studies will develop a model of rat liver cells grown in a 3-dimensional format and pair that with an efficient, high-content analytical platform that will provide information on DNA function and cell health. The value of these types of models is significant for both basic science and more targeted research efforts such as human safety studies. Assessment of the safety of compounds like drug candidates, industrial chemicals and consumer products relies on preclinical test models to report useful information of human safety. The ability of cell-based models to do this is often challenged when the in vitro and in vivo systems lack sufficient relevancy to the human condition. The proposed 3D organ models may overcome existing limitations and result in lower costs while providing better information. The combination of data-rich assays that enable fast and efficient assessment of in vitro animal-derived organ models represents an opportunity to improve safety testing and create tools that will benefit numerous other research initiatives that rely on in vitro systems.

IC Name
NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES
  • Activity
    R43
  • Administering IC
    ES
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    176622
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    113
  • Ed Inst. Type
  • Funding ICs
    NIEHS:176622\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZES1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    LITRON LABORATORIES, LTD.
  • Organization Department
  • Organization DUNS
    085992055
  • Organization City
    ROCHESTER
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    146232860
  • Organization District
    UNITED STATES